
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 11.430 | 13.000 | 1.570 |
Shares | 74.360 | 74.360 | 0.000 |
Bonds | 14.210 | 14.210 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 26.918 | 21.957 |
Price to Book | 6.217 | 4.817 |
Price to Sales | 6.407 | 3.422 |
Price to Cash Flow | 18.614 | 14.751 |
Dividend Yield | 0.472 | 1.523 |
5 Years Earnings Growth | 10.243 | 10.177 |
Name | Net % | Category Average |
---|---|---|
Technology | 39.890 | 31.656 |
Communication Services | 19.400 | 10.153 |
Healthcare | 16.270 | 13.385 |
Financial Services | 14.510 | 13.407 |
Consumer Cyclical | 9.930 | 11.818 |
Number of long holdings: 16
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
iShares Short Treasury Bond ETF | - | 25.55 | - | - | |
NVIDIA | US67066G1040 | 7.54 | 141.72 | +1.24% | |
Palo Alto Networks | US6974351057 | 7.46 | 199.60 | +1.26% | |
Amazon.com | US0231351067 | 7.38 | 213.57 | +2.72% | |
Alphabet C | US02079K1079 | 7.28 | 174.92 | +3.01% | |
Meta Platforms | US30303M1027 | 7.14 | 697.71 | +1.91% | |
Eli Lilly | US5324571083 | 6.99 | 769.88 | +0.55% | |
Microsoft | US5949181045 | 5.50 | 470.38 | +0.58% | |
Intuitive Surgical | US46120E6023 | 5.10 | 557.08 | -0.18% | |
Berkshire Hathaway B | US0846707026 | 4.16 | 493.53 | +0.98% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CI Fondo BF-4 | 2.03B | -7.79 | 22.68 | - | ||
CI Fondo A | 2.03B | -6.66 | 26.37 | - | ||
CI Fondo BF-2 | 2.03B | -7.46 | 23.75 | - | ||
CI Fondos SA de CV SIID BF-4 | 9.06M | 17.62 | 6.34 | - | ||
CI Crecimiento A | 9.06M | 19.30 | 9.74 | 6.09 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review